Company Filing History:
Years Active: 2023
Title: Ke Huang - Innovator in Gene Therapy
Introduction
Ke Huang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of gene therapy, particularly through his innovative lipid compounds and formulations. With a total of 2 patents, his work is paving the way for advancements in pharmaceutical preparations.
Latest Patents
Ke Huang's latest patents include "Lipid compound as well as lipid vector, nucleic acid lipid nanoparticle composition, and pharmaceutical preparation comprising the same." This patent focuses on a series of lipid compounds and vectors that exhibit pH responsiveness and high encapsulation efficiency for nucleic acid drugs. His research aims to enhance the in-vivo delivery efficiency of these drugs, making them more effective in targeting specific organs. Another notable patent is "Lipid compound as well as lipid carrier, nucleic acid lipid nanoparticle composition and pharmaceutical preparation containing same." This invention also emphasizes the importance of lipid carriers in gene therapy, showcasing the potential for tailored drug delivery based on organ-specific needs.
Career Highlights
Ke Huang is currently associated with Purecodon (Hong Kong) Biopharma Ltd., where he continues to innovate in the field of gene therapy. His work is characterized by a strong focus on developing lipid-based solutions that improve the delivery and efficacy of nucleic acid drugs.
Collaborations
Ke Huang collaborates with notable colleagues such as Yingwen Li and Yuping Liu, contributing to a dynamic research environment that fosters innovation and development in gene therapy.
Conclusion
Ke Huang's contributions to gene therapy through his innovative lipid compounds and formulations are noteworthy. His patents reflect a commitment to enhancing drug delivery systems, which hold great promise for future medical applications.